The global Diabetes Nutrition Market is estimated to be valued at US$ 5719.26 Mn or Million in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Diabetes nutrition involves a balanced diet that helps manage blood sugar levels, reduce the risk of diabetes complications and aid overall health. Products include low-glycemic index foods, proteins, fibers and micronutrients. Effective diabetes nutrition provides energy for daily activities and helps prevent potential side effects.
Market key trends:
One of the key trends in the diabetes nutrition market is the rising demand for plant-based diabetes foods and supplements. With growing awareness about the benefits of plant-based nutrition, companies are launching various vegetable-based options such as soy, lentil, fruits and grains which are low in carbohydrates and sugars. For instance, Essens launched plant-based low GI protein shakes. These plant-based products aid better blood sugar control while also catering to the rising vegan and vegetarian consumer base. Such innovative plant-based offerings are expected to drive the market during the forecast period.
SWOT Analysis
Strength: The diabetes nutrition market has a large consumer base as diabetes is highly prevalent. It offers specialized nutrition products tailored for diabetes patients.
Weakness: The prices of diabetes specific nutrition products are generally higher compared to normal food items which may limit their adoption. Product awareness is still low in many developing nations.
Opportunity: Rising diabetes rates globally due to sedentary lifestyles and obesity creates scope for market growth. Developing personalized nutrition solutions through advanced technologies present opportunities.
Threats: Introduction of generic alternatives and nutritional supplements by local players increases competition. Stringent regulations associated with new product approvals can delay entries of innovative products.
Key Takeaways
The Global Diabetes Nutrition Market Size is expected to witness high growth, exhibiting CAGR of 6.5% over the forecast period, due to increasing prevalence of diabetes worldwide. As per IDF data, around 700 million people are projected to have diabetes by 2045. This growing patient base will propel the demand for effective diabetes-specific nutrition products.
The North America region currently dominates the diabetes nutrition market, owing to high awareness levels and demand for specialized dietary regimes in the U.S. and Canada. However, Asia Pacific region is expected to witness the fastest growth during the forecast period. This can be attributed to improving healthcare infrastructure and rapidly growing diabetes patient pool in highly populated countries of India and China.
Key players operating in the diabetes nutrition market are Nestle, Fresenius Kabi AG, Abbott, Danone S.A., Eli Lilly and Company, Diabetain, Essens Wellness Technologies Private Limited, Medlife, BestSource Nutrition Pvt. Ltd., Inlife Pharma Pvt. Ltd., B Jain Pharmaceuticals Private Limited, PT Kalbe Farma Tbk, Natxtra, Unique Biotech Limited (UBL), Newtrition Plus Health & Wellness Pvt. Ltd., Venus Remedies Limited, Zemaica Healthcare. These players are focusing on expanding their product portfolios and global footprints through collaborations and mergers & acquisitions.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
